177 related articles for article (PubMed ID: 25942999)
1. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
[TBL] [Abstract][Full Text] [Related]
2. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
[TBL] [Abstract][Full Text] [Related]
4. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
Miller DE; Roane TE; Salo JA; Hardin HC
J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
Almodóvar AS; Nahata MC
J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
Lee JS; Yang J; Stockl KM; Lew H; Solow BK
J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
[TBL] [Abstract][Full Text] [Related]
10. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
[TBL] [Abstract][Full Text] [Related]
11. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
12. Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
Farris KB; Salgado TM; Aneese N; Marshall VD; Pendergast JF; Frank J; Chrischilles EA; Doucette WR
J Manag Care Spec Pharm; 2016 Apr; 22(4):388-95. PubMed ID: 27023692
[TBL] [Abstract][Full Text] [Related]
13. Qualitative analysis of telephonic comprehensive medication review content and delivery.
Dhatt H; Vaffis S; Le D; Axon DR; Campbell PJ; Black H; Kolobova I; Nelson ML; Warholak T
J Am Pharm Assoc (2003); 2023; 63(2):555-565. PubMed ID: 36481091
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with medication-related problems in an ambulatory medicare population and the case for medication therapy management.
Rogan EL; Ranson CA; Valle-Oseguera CS; Lee C; Gumberg A; Nagin BN; Cao W; Wang E; Trinh C; Chan K; Samra NK; Hou EW; Patel RA
Res Social Adm Pharm; 2020 Jun; 16(6):783-786. PubMed ID: 31447267
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
Trials; 2015 Jan; 16():2. PubMed ID: 25572800
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.
Yoo A; Fennelly JE; Renauer MM; Coe AB; Choe HM; Marshall VD; Parsons D; Farris KB
J Am Pharm Assoc (2003); 2022; 62(2):580-587.e1. PubMed ID: 34696978
[TBL] [Abstract][Full Text] [Related]
17. Impact of telephonic comprehensive medication reviews on patient outcomes.
DeZeeuw EA; Coleman AM; Nahata MC
Am J Manag Care; 2018 Feb; 24(2):e54-e58. PubMed ID: 29461851
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
[TBL] [Abstract][Full Text] [Related]
19. Online Provision of Part D Medication Therapy Management Program Information.
Tong Z; Cooke CE; Brandt NJ
J Manag Care Spec Pharm; 2019 Aug; 25(8):898-903. PubMed ID: 31347982
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
Welch EK; Delate T; Chester EA; Stubbings T
Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
